Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline

Journal of Medical Microbiology

Volumn 56, Issue 12, 2007, Pages 1692-1695

  Stanzani, Marta ^a   Tumietto, Fabio ^a   Giannini, Maria Benedetta ^a   Bianchi, Giuseppe ^b   Nanetti, Anna ^a   Vianelli, Nicola ^a   Arpinati, Mario ^a   Giovannini, Maddalena ^a   Bonifazi, Francesca ^a   Bandini, Giuseppe ^a   Baccarani, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BUSULFAN; CALCIUM SULFATE; CARBAPENEM; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; COLISTIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MEROPENEM; METHOTREXATE; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; RIFAMPICIN; THYMOCYTE ANTIBODY; TIGECYCLINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BONE MARROW TRANSPLANTATION; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MINOCYCLINE; OSTEOMYELITIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 37249087947     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47286-0     Document Type: Article

References (16)

1. Babinchak, T., Ellis-Grosse, E., Dartois, N., Rose, G. M., Loh, E. & the Tigecycline 301 and 306 Study Groups (2005). The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 41 (Suppl. 5), S354-S367.
2. Chatzinikolaou, I., Abi-Said, D., Bodey, G. P., Rolston, K. V. I., Tarrand, J. J. & Samonis, G. (2000). Recent experience with Pseudomonas aeruginosa bacteremia in a patient with cancer. Arch Intern Med 160, 501-509.
3. Doan, T. L., Fung, H. B., Mehta, D. & Riska, P. F. (2006). Tigecycline: a glycylcycline antimicrobial agent. Clin Ther 28, 1079-1106.
4. Ellis-Grosse, E. J., Babinchak, T., Dartois, N., Rose, G. M., Loh, E. & the Tigecycline 300 and 305 cSSSI Study Groups (2005). The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 41 (Suppl. 5), S341-S353.
5. Falagas, M. E. & Kasiakou, S. K. (2006). Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10, R27.
6. Jones, M. E., Karlowsky, J. A., Draghi, D. C., Thornsberry, C., Sahm, D. F. & Nathwani, D. (2004). Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy. Int J Antimicrob Agents 23, 240-246.
7. Nelson, C. L., McLaren, S. G., Skinner, R. A., Smeltzer, M. S., Thomas, J. R. & Olsen, K. M. (2002). The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res 20, 643-647.
8. Parody, R., Martino, R., Rovira, M., Vazquez, L., Vazquez, M. J., de la Cámara, R., Blazquez, C., Fernández-Avilés, F., Carreras, E. & other authors (2006). Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Bone Marrow Transplant 12, 734-748.
9. Rahal, J. J. (2006). Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 43, S95-S99.
10. Sader, H. S., Jones, R. N., Dowzicky, M. J. & Fritsche, T. R. (2005a). Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 52, 203-208.
11. Sader, H. S., Jones, R. N., Stilwell, M. G., Dowzicky, M. J. & Fritsche, T. R. (2005b). Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Diagn Microbiol Infect Dis 52, 181-186.
12. Tice, A. D., Hoaglund, P. A. & Shoultz, D. A. (2003). Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 51, 1261-1268.
13. Timurkaynak, F., Can, F., Azap, O. K., Demirbilek, M., Arslan, H. & Karaman, S. O. (2006). In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant stains of Pseudomonas aeruginosa and Acinetobacter baumanii isolated from intensive care units. Int J Antimicrob Agents 27, 224-228.
14. Townsend, M. L., Pound, M. W. & Drew, R. H. (2006). Tigecycline: a new glycylcycline antimicrobial. Int J Clin Pract 60, 1662-1672.
15. Williamson, E. C., Millar, M. R., Steward, C. G., Cornish, J., Foot, A., Oakhill, A., Pamphilon, D., Reeves, B., Caul, E. O. & other authors (1999). Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 104, 560-568.
16. Yin, L. Y., Lazzarini, L., Li, F., Stevens, C. M. & Calhoun, J. H. (2005). Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother 55, 995-1002.